How should I prepare and initiate an intravenous insulin drip (regular insulin) for a patient, including order requirements, dilution, infusion setup, and monitoring?

How to Prepare for Insulin Drip (Intravenous Insulin Infusion)

Verify the Order and Indication

Before preparing any insulin infusion, confirm that the patient meets criteria for IV insulin rather than subcutaneous therapy. IV insulin is indicated for critically ill patients requiring vasopressor support, type 1 diabetic patients in the ICU, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and situations requiring rapid, flexible titration.11

• Check that serum potassium is ≥3.3 mEq/L before starting insulin—this is an absolute contraindication with Class A evidence, as lower values can precipitate fatal cardiac arrhythmias.112
• Obtain baseline labs: glucose, electrolytes (especially potassium), venous pH, bicarbonate, anion gap, BUN, creatinine, and osmolality.12
• If DKA is suspected, measure serum or urine ketones; β-hydroxybutyrate is preferred over nitroprusside methods.12

Prepare the Insulin Solution

Mix 100 units of regular human insulin in 100 mL of 0.9% sodium chloride to create a 1 U/mL concentration—this standardized preparation minimizes dosing errors and allows consistent titration across all ICU settings.112

• Use only regular (short-acting) insulin for IV infusion; rapid-acting analogs (lispro, aspart, glulisine) must never be given intravenously.2
• Label the bag clearly with "Regular Insulin 100 U in 100 mL NS (1 U/mL)" and the preparation date/time.12

Prime the Infusion Tubing

Flush the IV tubing with 20 mL of the prepared insulin solution before connecting to the patient—this step prevents insulin adsorption to the tubing walls and ensures accurate delivery from the first moment.112

• Discard the priming volume into a waste container, not into the patient.11
• Use a dedicated IV line for insulin whenever possible to avoid medication interactions.1

Set Up Concurrent Dextrose Infusion (If Applicable)

For DKA management, prepare to add dextrose-containing fluids when plasma glucose falls to approximately 250 mg/dL—this allows continued insulin infusion to clear ketones while preventing hypoglycemia.123

• Have D5W with 0.45% or 0.75% NaCl ready at bedside.12
• In euglycemic DKA (initial glucose <250 mg/dL), start dextrose infusion simultaneously with insulin from the outset.2
• Typical dextrose delivery is 100-150 g/day (e.g., D10W at 40 mL/h provides ~96 g/day).12

Establish Potassium Replacement Protocol

Prepare potassium supplementation using a mixture of 2/3 potassium chloride (or acetate) and 1/3 potassium phosphate—this addresses both potassium and phosphate depletion simultaneously.12

• Add 20-30 mEq/L potassium to IV fluids once serum K+ is <5.5 mEq/L and urine output is adequate (≥0.5 mL/kg/h).12
• Target serum potassium 4.0-5.0 mEq/L throughout insulin infusion.112
• Monitor potassium every 2-4 hours during active insulin therapy, as insulin drives potassium intracellularly.112

Determine Initial Insulin Infusion Rate

For DKA (Moderate-Severe)

Give an IV bolus of 0.1 U/kg regular insulin, then start continuous infusion at 0.1 U/kg/h (approximately 5-7 U/h in adults)—this achieves a target glucose decline of 50-75 mg/dL per hour.123

• In pediatric patients, omit the initial bolus and start infusion at 0.05-0.1 U/kg/h to reduce cerebral edema risk.123
• If glucose does not fall by 50 mg/dL in the first hour, verify hydration status and double the infusion rate hourly until achieving steady decline.12

For General ICU Hyperglycemia (Non-DKA)

Start at 0.5-1 U/h and adjust based on glucose checks every 1-2 hours—target glucose 140-180 mg/dL for most critically ill patients.12

• More stringent targets of 110-140 mg/dL may be considered in selected cardiac surgery patients if achievable without significant hypoglycemia.11

Set Up Glucose Monitoring

Check bedside glucose every 1-2 hours during initial titration, then every 2-4 hours once stable—frequent monitoring is essential to prevent hypoglycemia, which occurs in protocols using 4-hourly checks.12

• Use arterial or venous blood (from the opposite side of glucose infusion) rather than capillary samples when possible.1
• For DKA, also measure venous pH, bicarbonate, and anion gap every 2-4 hours until metabolically stable.12

Prepare Hypoglycemia Treatment

Have 10% dextrose available in 50-mL aliquots (5 g each) at bedside—this is the preferred concentration for treating hypoglycemia during insulin infusion, as 50% dextrose causes over-correction.1

• Treat any glucose <70 mg/dL immediately with 10% dextrose, repeating every minute until symptoms resolve.1
• Never reduce or stop insulin infusion when glucose normalizes during DKA—add dextrose instead to continue ketone clearance.2

Plan the Transition to Subcutaneous Insulin

Administer long-acting basal insulin (glargine or detemir) 2-4 hours before stopping the IV infusion—this overlap is critical to prevent rebound hyperglycemia and recurrent DKA.1123

• Continue IV insulin for an additional 1-2 hours after the subcutaneous basal dose to ensure adequate absorption.12
• Calculate subcutaneous dose as approximately 50% of the total 24-hour IV insulin amount as basal, with the remaining 50% divided among three meals as rapid-acting insulin.12
• Never stop IV insulin abruptly without prior basal insulin overlap—this is the most common cause of recurrent DKA.12

Common Pitfalls to Avoid

• Do not start insulin if potassium <3.3 mEq/L—this can cause fatal arrhythmias.112
• Do not use rapid-acting insulin analogs IV—only regular insulin is appropriate.2
• Do not hold insulin when glucose falls during DKA—add dextrose while maintaining insulin to clear ketones.2
• Do not rely on urine ketones alone—they lag behind serum β-hydroxybutyrate clearance.12
• Do not stop IV insulin without 2-4 hour basal insulin overlap—this causes DKA recurrence.12